Effects of hepatitis B vaccination on hepatitis B surface antigen in neonates and its change in vivo

[1] Karayiannis P. Hepatitis B virus: virology, molecular biology, life cycle and intrahepatic spread. Hepatol Int. 2017; 11:500–8. KarayiannisP Hepatitis B virus: virology, molecular biology, life cycle and intrahepatic spread Hepatol Int 2017 11 500 8 Search in Google Scholar

[2] World Health Organization. Hepatitis B vaccines: WHO position paper, July 2017 – Recommendations. Vaccine. 2019; 37:223–5. World Health Organization Hepatitis B vaccines: WHO position paper, July 2017 – Recommendations Vaccine 2019 37 223 5 Search in Google Scholar

[3] Nelson NP, Easterbrook PJ, McMahon BJ. Epidemiology of Hepatitis B virus infection and impact of vaccination on disease. Clin Liver Dis. 2016; 20:607–28. NelsonNP EasterbrookPJ McMahonBJ Epidemiology of Hepatitis B virus infection and impact of vaccination on disease Clin Liver Dis 2016 20 607 28 Search in Google Scholar

[4] Trépo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014; 384(9959):2053–63. TrépoC ChanHL LokA Hepatitis B virus infection Lancet 2014 384 9959 2053 63 Search in Google Scholar

[5] Yuen M-F, Chen D-S, Dusheiko GM, Janssen HLA, Lau DTY, Locarnini SA, et al. Hepatitis B virus infection. Nat Rev Dis Primers. 2018; 4:18035. doi: 10.1038/nrdp.2018.35 YuenM-F ChenD-S DusheikoGM JanssenHLA LauDTY LocarniniSA Hepatitis B virus infection Nat Rev Dis Primers 2018 4 18035 10.1038/nrdp.2018.35 Open DOISearch in Google Scholar

[6] Zu J, Li M, Zhuang G, Liang P, Cui F, Wang F, et al. Estimating the impact of test-and-treat strategies on hepatitis B virus infection in China by using an age-structured mathematical model. Medicine (Baltimore). 2018; 97:e484. doi: 10.1097/MD.0000000000010484 ZuJ LiM ZhuangG LiangP CuiF WangF Estimating the impact of test-and-treat strategies on hepatitis B virus infection in China by using an age-structured mathematical model Medicine (Baltimore) 2018 97 e484 10.1097/MD.0000000000010484 Open DOISearch in Google Scholar

[7] Zampino R, Boemio A, Sagnelli C, Alessio L, Adinolfi LE, Sagnelli E, Coppola N. Hepatitis B virus burden in developing countries. World J Gastroenterol. 2015; 21:11941–53. ZampinoR BoemioA SagnelliC AlessioL AdinolfiLE SagnelliE CoppolaN Hepatitis B virus burden in developing countries World J Gastroenterol 2015 21 11941 53 Search in Google Scholar

[8] Wang H, Men P, Xiao Y, Gao P, Lv M, Yuan Q, et al. Hepatitis B infection in the general population of China: a systematic review and meta-analysis. BMC Infect Dis. 2019; 19:811. doi: 10.1186/s12879-019-4428-y WangH MenP XiaoY GaoP LvM YuanQ Hepatitis B infection in the general population of China: a systematic review and meta-analysis BMC Infect Dis 2019 19 811 10.1186/s12879-019-4428-y Open DOISearch in Google Scholar

[9] Locarnini S, Hatzakis A, Chen D, Lok A. Strategies to control hepatitis B: public policy, epidemiology, vaccine and drugs. J Hepatol. 2015; 62(1 Suppl):S76–86. LocarniniS HatzakisA ChenD LokA Strategies to control hepatitis B: public policy, epidemiology, vaccine and drugs J Hepatol 2015 62 1 Suppl S76 86 Search in Google Scholar

[10] Zhang S, Wang F, Zhang Z. Current advances in the elimination of hepatitis B in China by 2030. Front Med. 2017; 11:490–501. ZhangS WangF ZhangZ Current advances in the elimination of hepatitis B in China by 2030 Front Med 2017 11 490 501 Search in Google Scholar

[11] Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis. 2010; 14:1–21, vii. doi: 10.1016/j.cld.2009.11.009 TeHS JensenDM Epidemiology of hepatitis B and C viruses: a global overview Clin Liver Dis 2010 14 1 21 vii 10.1016/j.cld.2009.11.009 Open DOISearch in Google Scholar

[12] Liu J, Liang W, Jing W, Liu M. Countdown to 2030: eliminating hepatitis B disease, China. Bull World Health Organ. 2019; 97:230–8. LiuJ LiangW JingW LiuM Countdown to 2030: eliminating hepatitis B disease, China Bull World Health Organ 2019 97 230 8 Search in Google Scholar

[13] Lamberth JR, Reddy SC, Pan JJ, Dasher KJ. Chronic hepatitis B infection in pregnancy. World J Hepatol. 2015; 7:1233–7. LamberthJR ReddySC PanJJ DasherKJ Chronic hepatitis B infection in pregnancy World J Hepatol 2015 7 1233 7 Search in Google Scholar

[14] Xu SDL. Less than a 10th of China’s couples apply to have second child. BMJ. 2015; 350:h352. doi: 10.1136/bmj.h352 XuSDL Less than a 10th of China’s couples apply to have second child BMJ 2015 350 h352 10.1136/bmj.h352 Open DOISearch in Google Scholar

[15] Li Q, Deng D. New medical risks affecting obstetrics after implementation of the two-child policy in China. Front Med. 2017; 11:570–5. LiQ DengD New medical risks affecting obstetrics after implementation of the two-child policy in China Front Med 2017 11 570 5 Search in Google Scholar

[16] Mak L-Y, Seto W-K, Fung J, Yuen M-F. Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B. Hepatol Int. 2020; 14:35–46. MakL-Y SetoW-K FungJ YuenM-F Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B Hepatol Int 2020 14 35 46 Search in Google Scholar

[17] Yi P, Chen R, Huang Y, Zhou R-R, Fan X-G. Management of mother-to-child transmission of hepatitis B virus: propositions and challenges. J Clin Virol. 2016; 77:32–9. YiP ChenR HuangY ZhouR-R FanX-G Management of mother-to-child transmission of hepatitis B virus: propositions and challenges J Clin Virol 2016 77 32 9 Search in Google Scholar

[18] Katkov WN, Ault MJ, Dubin SB. Absence of hepatitis B surface antigenemia after vaccination. Arch Pathol Lab Med. 1989;113:1290. KatkovWN AultMJ DubinSB Absence of hepatitis B surface antigenemia after vaccination Arch Pathol Lab Med 1989 113 1290 Search in Google Scholar

[19] Ziaee M, Saádatjoo A, Mohamadpour M, Namaei MH. Induced HBs antigenemia in healthy adults after immunization with two different hepatitis B recombinant vaccines. Hepati Mon. 2010; 10:298–301. ZiaeeM SaádatjooA MohamadpourM NamaeiMH Induced HBs antigenemia in healthy adults after immunization with two different hepatitis B recombinant vaccines Hepati Mon 2010 10 298 301 Search in Google Scholar

[20] Ly D, Yee HF Jr, Brezina M, Martin P, Gitnick G, Saab S. Hepatitis B surface antigenemia in chronic hemodialysis patients: effect of hepatitis B immunization. Am J Gastroenterol. 2002; 97:138–41. LyD YeeHFJr BrezinaM MartinP GitnickG SaabS Hepatitis B surface antigenemia in chronic hemodialysis patients: effect of hepatitis B immunization Am J Gastroenterol 2002 97 138 41 Search in Google Scholar

[21] Lunn ER, Hoggarth BJ, Cook WJ. Prolonged hepatitis B surface antigenemia after vaccination. Pediatrics. 2000; 105:E81. doi: 10.1542/peds.105.6.e81 LunnER HoggarthBJ CookWJ Prolonged hepatitis B surface antigenemia after vaccination Pediatrics 2000 105 E81 10.1542/peds.105.6.e81 Open DOISearch in Google Scholar

[22] Habib S, Shaikh OS. Hepatitis B immune globulin. Drugs Today (Barc). 2007; 43:379–94. HabibS ShaikhOS Hepatitis B immune globulin Drugs Today (Barc) 2007 43 379 94 Search in Google Scholar

[23] Eke AC, Eleje GU, Eke UA, Xia Y, Liu J. Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus. Cochrane Database Syst Rev. 2017; 2:CD008545. doi: 10.1002/14651858.CD008545.pub2 EkeAC ElejeGU EkeUA XiaY LiuJ Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus Cochrane Database Syst Rev 2017 2 CD008545 10.1002/14651858.CD008545.pub2 Open DOISearch in Google Scholar

[24] Hu Y, Wu Q, Xu B, Zhou Z, Wang Z, Zhou Y-H. Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants. Vaccine. 2008; 26:6064–7. HuY WuQ XuB ZhouZ WangZ ZhouY-H Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants Vaccine 2008 26 6064 7 Search in Google Scholar

[25] Wang Z, Zhang S, Luo C, Wu Q, Liu Q, Zhou Y-H, Hu Y. Transplacentally acquired maternal antibody against hepatitis B surface antigen in infants and its influence on the response to hepatitis B vaccine. PLoS One. 2011; 6:e25130. doi: 10.1371/journal.pone.0025130 WangZ ZhangS LuoC WuQ LiuQ ZhouY-H HuY Transplacentally acquired maternal antibody against hepatitis B surface antigen in infants and its influence on the response to hepatitis B vaccine PLoS One 2011 6 e25130 10.1371/journal.pone.0025130 Open DOISearch in Google Scholar

[26] Rysgaard CD, Morris CS, Drees D, Bebber T, Davis SR, Kulhavy J, Krasowski MD. Positive hepatitis B surface antigen tests due to recent vaccination: a persistent problem. BMC Clin Pathol. 2012; 12:15. doi: 10.1186/1472-6890-12-15 RysgaardCD MorrisCS DreesD BebberT DavisSR KulhavyJ KrasowskiMD Positive hepatitis B surface antigen tests due to recent vaccination: a persistent problem BMC Clin Pathol 2012 12 15 10.1186/1472-6890-12-15 Open DOISearch in Google Scholar

[27] Sharma S, Saini N, Arora L, Chawla Y, Duseja A. Prolonged hepatitis B surface antigen positivity in hepatitis B vaccine recipients. Dig Liver Dis. 2006; 38:860–1. SharmaS SainiN AroraL ChawlaY DusejaA Prolonged hepatitis B surface antigen positivity in hepatitis B vaccine recipients Dig Liver Dis 2006 38 860 1 Search in Google Scholar

[28] Köksal N, Altinkaya N, Perk Y. Transient hepatitis B surface antigenemia after neonatal hepatitis B immunization. Acta Paediatr. 1996; 85:1501–2. KöksalN AltinkayaN PerkY Transient hepatitis B surface antigenemia after neonatal hepatitis B immunization Acta Paediatr 1996 85 1501 2 Search in Google Scholar

[29] von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology. 2007; 18:800–4. von ElmE AltmanDG EggerM PocockSJ GotzschePC VandenbrouckeJP The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies Epidemiology 2007 18 800 4 Search in Google Scholar